1. Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. (9th February 2021) Authors: Strickler, John H.; Rushing, Christel N.; Uronis, Hope E.; Morse, Michael A.; Niedzwiecki, Donna; Blobe, Gerard C.; Moyer, Ashley N.; Bolch, Emily; Webb, Renee; Haley, Sherri; Hatch, Ace J.; Altomare, Ivy P.; Sherrill, Gary B.; Chang, David Z.; Wells, James L.; Hsu, S. David; Jia, Jingquan; Zafar... Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer. (9th February 2021) Authors: Strickler, John H.; Rushing, Christel N.; Uronis, Hope E.; Morse, Michael A.; Niedzwiecki, Donna; Blobe, Gerard C.; Moyer, Ashley N.; Bolch, Emily; Webb, Renee; Haley, Sherri; Hatch, Ace J.; Altomare, Ivy P.; Sherrill, Gary B.; Chang, David Z.; Wells, James L.; Hsu, S. David; Jia, Jingquan; Zafar... Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗